AKE — Allkem Share Price
- CA$5.62bn
- CA$5.19bn
- $1.21bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 10.6 | ||
PEG Ratio (f) | 15.14 | ||
EPS Growth (f) | 0.7% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.24 | ||
Price to Tang. Book | 1.46 | ||
Price to Free Cashflow | 16.39 | ||
Price to Sales | 3.48 | ||
EV to EBITDA | 4.34 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 17.39% | ||
Return on Equity | 13.92% | ||
Operating Margin | 68.71% |
Financial Summary
Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 81.15 | 77.08 | 84.76 | 744.68 | 1,207.8 | 1,206.18 | 1,505.78 | 133.56% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +500 | n/a | n/a | n/a | +33.17 | -22.6 | +28.44 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Allkem Limited is a specialty lithium chemicals company with a global portfolio of lithium chemicals. The Company is principally engaged in mineral extraction, production, and chemical processing. The Company’s segments include Olaroz, Mt Cattlin, James Bay, Sal De Vida projects, and Corporate. Its flagship Olaroz brine-based lithium facility is based in Northern Argentina and supplies lithium chemicals across the globe. The Mt Cattlin spodumene project (Mt Cattlin) produces spodumene concentrate utilizing conventional techniques to extract and process the resource. This wholly owned project is located two kilometers (km) north of the town of Ravensthorpe in Western Australia. The James Bay Project is located in northern Quebec, approximately 130 km east of James Bay and the Cree Nation of Eastmain community. Sal De Vida project is a tier one brine project, which is located in Catamarca Province on the Salar del Hombre Muerto. Its other project includes Cauchari mineral resource.
Directors
- Martin de Solay CEO
- Fernando Oris de Roa NVC
- Neil Kaplan CFO
- Rick Anthon GCN
- John Sanders SEC
- Alan Fitzpatrick NED
- Florencia Heredia NED
- Martin Rowley NED
- John Turner NED
- Leanne Heywood NID
- Richard Seville NID
- Last Annual
- June 30th, 2023
- Last Interim
- June 30th, 2023
- Incorporated
- January 20th, 2005
- Public Since
- December 4th, 2007
- No. of Shareholders
- 49,252
- No. of Employees
- 1,350
- Sector
- Metals & Mining
- Industry
- Basic Materials
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 637,422,864
- Address
- Level 35, 71 Eagle Street, BRISBANE, 4000
- Web
- https://www.allkem.co/
- Phone
- +61 738713985
- Contact
- Andrew Barber
- Auditors
- Ernst & Young
Upcoming Events for AKE
Similar to AKE
Aclara Resources
Toronto Stock Exchange
Adf
Toronto Stock Exchange
AgniCo Eagle Mines
Toronto Stock Exchange
Alamos Gold
Toronto Stock Exchange
Algoma Steel
Toronto Stock Exchange
FAQ
As of Today at 18:26 UTC, shares in Allkem are trading at CA$8.86. This share price information is delayed by 15 minutes.
Shares in Allkem last closed at CA$8.86 and the price had moved by +31.6% over the past 365 days. In terms of relative price strength the Allkem share price has outperformed the Toronto Stock Exchange 300 Composite Index by +24.55% over the past year.
The overall consensus recommendation for Allkem is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAllkem does not currently pay a dividend.
Allkem does not currently pay a dividend.
Allkem does not currently pay a dividend.
To buy shares in Allkem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$8.86, shares in Allkem had a market capitalisation of CA$5.62bn.
Here are the trading details for Allkem:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: AKE
Based on an overall assessment of its quality, value and momentum Allkem is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Allkem is CA$10.90. That is 23.06% above the last closing price of CA$8.86.
Analysts covering Allkem currently have a consensus Earnings Per Share (EPS) forecast of $0.55 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Allkem. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -2.05%.
As of the last closing price of CA$8.86, shares in Allkem were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Allkem PE ratio based on its reported earnings over the past 12 months is 10.6. The shares last closed at CA$8.86.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Allkem's management team is headed by:
- Martin de Solay - CEO
- Fernando Oris de Roa - NVC
- Neil Kaplan - CFO
- Rick Anthon - GCN
- John Sanders - SEC
- Alan Fitzpatrick - NED
- Florencia Heredia - NED
- Martin Rowley - NED
- John Turner - NED
- Leanne Heywood - NID
- Richard Seville - NID